Biotech Startups

Computomics develops AI and genomic foundation models for plant breeding, using machine learning on genetic, phenotypic, and environmental data to improve trait selection, prediction accuracy, and breeding cycle speed. It serves plant breeders and the agricultural sector working on resilient, high-yielding crops.

1 investor

1 investor

Conception Nurseries produces tissue culture micropropagated cannabis clones that are pest-free, disease-free, and genetically verified for commercial cannabis cultivators. The company applies proprietary biotechnology to enable scaled production of cannabis genetics while maintaining quality standards.

1 investor

Concinnity Genetics develops control mechanisms to improve the safety of cell and gene therapies, using an AI platform and synthetic biology to help biopharmaceutical partners design and optimise their gene therapies. Spun out of the University of Edinburgh in 2023, it serves gene therapy developers in the biopharmaceutical industry.

1 investor

Conexeu is developing CXU™, a collagen-based extracellular matrix (ECM) platform for soft-tissue regeneration intended as an alternative to static fillers, combining structural support with tissue in-growth and integration. The platform is positioned as a single formula and device with potential use across a range of human and animal regenerative medicine applications.

1 investor

Confience delivers a cloud-based Laboratory Information Management System (LIMS) for environmental, food and beverage, pharmaceutical, and industrial laboratories to eliminate manual data entry, maintain regulatory compliance, and ensure traceability from sample receipt to result delivery. The platform includes integrated field data collection, client portals, and direct instrument integration to reduce manual work and transcription errors.

1 investor

Confluence Genetics develops proprietary soybean varieties using an AI-driven breeding platform called CropOS® to deliver improved yields and quality traits. The company serves farmers and grain industry partners across the U.S. agricultural supply chain.

1 investor

Confluence Labs is an AI research lab developing models that improve learning efficiency, enabling faster scientific discovery with minimal experimental data. The company focuses on accelerating breakthroughs in drug and materials discovery by reducing the number of experiments needed to achieve results.

1 investor

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.

1 investor

Conquest Labs builds AI models to discover and develop cancer therapies by engineering multi-drug combinations that guide biological systems from diseased to healthy states. The company integrates computational drug discovery with laboratory feedback to identify new therapeutic approaches for cancer treatment.

1 investor

Bukwang Pharm is a South Korean pharmaceutical company that develops and licenses drugs for antiviral, gastrointestinal, CNS, and metabolic disorders. The company sells primarily licensed products from Europe, the United States, and Japan.

1 investor

Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.

1 investor

Convergent Therapeutics develops radioantibody-based (PSMA-targeted) therapies for cancers, including metastatic castration-resistant prostate cancer (mCRPC). The clinical-stage biotech is advancing radiopharmaceutical treatments backed by preclinical and clinical data.

1 investor

Convexia provides AI-powered drug discovery and evaluation software that scans global sources for overlooked drug assets and runs deep in silico simulations across 50+ models to assess binding, toxicity, pharmacokinetics, and immunogenicity. The platform combines AI agents with expert human review to accelerate drug asset evaluation for biotech companies, pharma firms, and venture investors.

1 investor

Coral Genomics develops laboratory tests that combine molecular, functional, and clinical data to guide treatment selection for patients with autoimmune diseases, including those resistant to existing therapies.

1 investor

Corbus Pharmaceuticals is a biopharmaceutical company developing therapies for critical stages of clinical development, with a focus on advancing patient-centered progress in drug development. The company is led by a senior leadership team with expertise in pharmaceutical research, regulatory affairs, and clinical development.

1 investor

CordenPharma is a contract development and manufacturing organization (CDMO) providing high-quality integrated product solutions to pharmaceutical and biotechnology companies across the complete drug lifecycle.

1 investor

Cordex Systems develops SmartCuff, a medical device that repurposes blood pressure cuff technology as a linear sensor to detect early warning signs of heart disease. The device is designed for healthcare professionals and patients at risk of cardiovascular disease.

1 investor

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals. The company serves individuals seeking medical diagnostic testing.

1 investor

Corealis Pharma is a contract development and manufacturing organization (CDMO) specializing in oral solid dosage formulation and GMP manufacturing for biotech companies developing complex therapies. The company provides services from early-stage formulation through clinical supply, with integrated R&D and manufacturing infrastructure based in Laval, Canada.

1 investor

CoreBone cultivates corals in a closed lab-based aquarium system to produce natural scaffolds for bone and cartilage tissue engineering, offering dental bone grafts as an alternative to bovine and human grafts. Its products serve dental and orthopedic surgical markets, with a cartilage regeneration platform advancing into clinical trials.

1 investor

1 investor

Cori Clinical builds an AI platform that automates the authoring and management of clinical trial documentation, including protocols, consent forms, and regulatory submissions. The platform serves clinical development teams by reducing manual document preparation and ensuring consistency across all trial-related paperwork.

1 investor

Corion Biotech develops therapeutic solutions for women's health, with a focus on pregnancy-related disorders such as preeclampsia and fetal growth restriction. The company was founded as an academic spin-off from the University of Turin based on over two decades of translational research in obstetrics and gynecology.

1 investor